Our team selected for Q4Bio phase 2!

After one year (Phase 1) of intensively developing our Wellcome Leap-supported quantum-for-biology (Q4Bio) project, we are very excited that our team was one of the 8 teams (out of 12 teams in Phase 1) that were selected to continue on to Phase 2! Some more news on this here.

Our amazing team represented at the Q4Bio PI meeting in London: (from left) Aram Harrow (MIT), Ryan Robinett (PhD student at UChicago), Sam Riesenfeld (UChicago), Teague Tomesh (Infleqtion), Fred Chong (Infleqtion and UChicago), and Alex Pearson (UChiacago).